imatinib mesylate has been researched along with Chylopericardium in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CN; Chou, AK; Fu, CM; Kung, PJ; Li, MJ; Liao, LC; Su, PY; Tan, BF | 1 |
| Carroll, SJ; Dayton, JD; Donovan, DJ; Holzer, RJ; Siskind, T; Thanjan, MT | 1 |
| Cai, J; Huang, J; Jiang, Q; Lin, H; Wu, L; Ye, Q | 1 |
| Aron, J; Avery, P; Morton, S; Terry, C | 1 |
| Asmis, T; Gilbert, S; Pysyk, CL | 1 |
| Bakanay, SM; Dilek, I; Kucuksahin, O; Maral, S | 1 |
| Giles, FJ; Kelly, K; Mahalingam, D; Padmanabhan, S; Swords, R | 1 |
| Alimena, G; Breccia, M | 1 |
| Barton, JC; Jones, SC; Lamberth, WC; Reymann, MT; Scott, VC | 1 |
| Alimena, G; Breccia, M; D'Andrea, M; D'Elia, GM; Latagliata, R | 1 |
2 review(s) available for imatinib mesylate and Chylopericardium
| Article | Year |
|---|---|
Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors.
Topics: Benzamides; Cell Proliferation; Cytotoxicity, Immunologic; Dasatinib; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Activation; Pericardial Effusion; Piperazines; Pleural Effusion; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Serositis; Thiazoles; Treatment Outcome | 2009 |
Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development.
Topics: Aged; Antineoplastic Agents; Autoimmune Diseases; Benzamides; Cardiovascular Diseases; Clinical Trials as Topic; Comorbidity; Dasatinib; Disease Management; Drug Administration Schedule; Drug Eruptions; Humans; Hypercholesterolemia; Imatinib Mesylate; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Pericardial Effusion; Piperazines; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome | 2010 |
8 other study(ies) available for imatinib mesylate and Chylopericardium
| Article | Year |
|---|---|
Concurrence of imatinib-induced massive pleural/pericardial effusion and Campylobacter bacteremia in an adolescent with chronic myeloid leukemia.
Topics: Adolescent; Antineoplastic Agents; Bacteremia; Campylobacter; Dasatinib; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Pericardial Effusion | 2022 |
Chylous pericardial effusion with cardiac tamponade in a child treated with imatinib.
Topics: Cardiac Surgical Procedures; Cardiac Tamponade; Child; Female; Humans; Imatinib Mesylate; Pericardial Effusion; Respiration Disorders | 2023 |
Fluid retention-associated adverse events in patients treated with BCR::ABL1 inhibitors based on FDA Adverse Event Reporting System (FAERS): a retrospective pharmacovigilance study.
Topics: Adverse Drug Reaction Reporting Systems; Chylothorax; Dasatinib; Female; Humans; Imatinib Mesylate; Pericardial Effusion; Pharmacovigilance; Pleural Effusion; Pulmonary Edema; Pyrimidines; Retrospective Studies; United States; United States Food and Drug Administration | 2023 |
Imatinib-induced pericardial effusion in a child.
Topics: Child; Graft vs Host Disease; Humans; Imatinib Mesylate; Male; Pericardial Effusion; Protein Kinase Inhibitors | 2019 |
Pleural and pericardial effusions in patient on tyrosine kinase inhibitor.
Topics: Aged; Female; Humans; Imatinib Mesylate; Neoplasms; Pericardial Effusion; Pleural Effusion; Protein Kinase Inhibitors; Protein-Tyrosine Kinases | 2018 |
Lupus-like symptoms with anti-RNP/Sm and anti-nuclear antibodies positivity: An extremely rare adverse event of dasatinib.
Topics: Dasatinib; Echocardiography; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lupus Erythematosus, Systemic; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines | 2020 |
Cardiac tamponade associated with imatinib mesylate therapy of chronic myelogenous leukemia.
Topics: Benzamides; Cardiac Tamponade; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pericardial Effusion; Piperazines; Pyrimidines; Radiography; Weight Gain | 2002 |
Pleural-pericardic effusion as uncommon complication in CML patients treated with Imatinib.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pericardial Effusion; Piperazines; Pleural Effusion; Pyrimidines | 2005 |